Compass Therapeutics：有希望但正在缩小的机会窗口 (NASDAQ:CMPX)
· seekingalpha.com
Compass Therapeutics因tovecimig在胆道癌中未能显示总生存期获益而遭遇重大挫折。在此阅读关于CMPX股票的更多信息。
I am now a contributor to Total Pharma Tracker, where you can join me for discussions, get my follow-ups on ideas, and specifically request ideas to explore. It...